Диссертация (1140211), страница 15
Текст из файла (страница 15)
Dekker, A. M.Arvin, D.S. Schmid // Journal of Infectious Diseases. — 2011. — Vol. 203(3). — P. 316–323;12.Science M. Central nervous system complications of varicella-zoster virus / M.Science, D. MacGregor, S. E. Richardson, S. Mahant, D. Tran, A. Bitnun // TheJournal of Pediatrics. — 2014. — Vol. 165(4). — P.
779–785;13.Mérelle М. E. Varicella: previously healthy children sometimes developcomplications / М. E. Mérelle, L. F. Visser, J.A. Bokma, H. E. deMelker, J. P. deWinter // Nederlands Tijdschrift voor Geneeskunde. — 2006. — Vol. 150(48). —P. 2625–2629;14.Spackova M. Complications of varicella after implementation of routinechildhood varicella vaccination in Germany / М. Spackova, М. Muehlen, A.Siedler // Pediatric Infectious Disease Journal. — 2010.
— Vol. 29. — P. 884–886;15.Скрипченко Н. В. Нейроинфекции у детей / Под ред. проф. Н. В.Скрипченко. ― СПб: Тактик-Студио, 2015. ― 856 с.;16.Пирадов М. И. Аутоиммунные заболевания нервной системы: состояниепроблемы и перспективы / И. М. Пирадов, Н. А. Супонева // Вестникроссийской академии медицинских наук. — 2015. — № 2. — С.
183–187;17.Львов Д. К. Вирусы и вирусные инфекции человека и животных.Руководство по вирусологии / под ред. Д. К. Львова. — М.: МИА, 2013. —С. 132–143;10018.Barnett E. M. Herpes simplex encephalitis in the temporal cortex and limbicsystem after trigeminal nerve inoculation / E. M. Barnett, G. Jacobsen, G. Evans,M. Cassell, S.
Perlman // The Journal of Infectious Diseases. — 1994. — Vol.169(4). — P. 782–786;19.Meyding-Lamadé U. Herpesvirus infections of the central nervous system inimmunocompromised patients / U. Meyding-Lamadé, C. Strank // TherapeuticAdvances in Neurological Disorders. — 2012. — Vol. 5. — P. 279–296;20.Gilden D. H. Herpesvirus infections of the nervous system / D. H. Gilden, R.Mahalingam, R. J. Cohrs, K. L. Tyler // Nature Clinical Practice Neurology.
—2007. — Vol. 3 — P. 82–94;21.Weil A. A. Patients with suspected herpes simplex encephalitis: rethinking aninitial negative polymerase chain reaction result / A. A. Weil, C. A. Glaser, Z.Amad, B. Forghani // Clinical Infectious Diseases. — 2002. — Vol. 34(8). — P.1154–1157;22.Stahl J. P. Herpes simplex encephalitis and management of acyclovir inencephalitis patients in France / J. P. Stahl, А. Mailles, Т. De Broucker //Epidemiology and Infection. — 2012.
— Vol. 140(2). — P. 372–381;23.Johnson R. T. Acute encephalitis/ R. T. Johnson // Clinical Infectious Diseases.— 1996. — Vol. 23 (2). — P. 219–224;24.Whitley R. Neonatal herpes simplex virus infection / R. Whitley // CurrentOpinion in Infectious Diseases. — 2004. — Vol. 17 (3). — P.
243–246;25.Schlesinger Y. Expanded spectrum of herpes simplex encephalitis in childhood /Y. Schlesinger, R. S. Buller, J. E. Brunstrom, C. J. Moran, G. A. Storch // Journalof Pediatrics. — 1995. — Vol. 126 (2). — P. 234–241;26.Kelly B. J. Identification of host cell proteins which interact with herpes simplexvirus type 1 tegument protein pUL37 / B. J. Kelly, E.
Diefenbach, C. Fraefel, R. J.Diefenbach // Biochemical and Biophysical Research Communications. — 2012— Vol. 417(3). — P. 961–965;10127.Klupp B. G. Pseudorabies virus UL36 tegument protein physically interacts withthe UL37 protein / B. G. Klupp, W. Fuchs, H. Granzow, R. Nixdorf, T. C.Mettenleiter // Journal of Virology. — 2002. — Vol. 76(6).
— P. 3065– 3071;28.Koelle D. M. Herpes simplex: insights on pathogenesis and possible vaccines / M.Koelle, L. Corey // Annual review of medicine. — 2008. — Vol. 59. — P. 381–395;29.Wolfstein A. The inner tegument promotes herpes simplex virus capsid motilityalong microtubules in vitro / A. Wolfstein, C. H. Nagel, K.
Radtke, K. Dohner, V.J. Allan, B. Sodeik // Traffic. — 2006. — Vol. 7(2). — P. 227–237;30.Corey L. Genital herpes simplex virus infections: clinical manifestations, course,and complications / L. Corey, H. G. Adams, Z. A. Brown, K. K. Holmes // Annalsof Internal Medicine. — 1983. — Vol. 98(6). — P. 958–972;31.Bergstrom T. Primary and recurrent herpes simplex virus type 2-inducedmeningitis / T. Bergstrom, A.
Vahlne, K. Alestig, S. Jeansson, M. Forsgren, E.Lycke // Journal of Infectious Diseases. — 1990. — Vol. 162(2). — P. 322– 330;32.Schott G. D. Triggering of delayed-onset postherpetic neuralgia / G. D. Schott //Lancet. — 1998. — Vol. 351(9100). — P. 419-420;33.Jensenius M. Herpes simplex virus type 2 DNAdetected in cerebrospinal fluid of9 patients with Mollaret's meningitis / M. Jensenius, B.
Myrvang, G. Stоrvold, A.Bucher, K. B. Hellum, A. L. Bruu // Acta Neurologica Scandinavica. — 1998. —Vol. 98(3). — P. 209–212;34.Kelly B. J. Functional roles of the tegument proteins of herpes simplex virus type1 / B. J. Kelly, C. Fraefel, A. L. Cunningham, R. J. Diefenbach // Virus Research.— 2009. — Vol.
145(2). — P. 173–186;35.Berger J. R. Benign aseptic (Mollaret's) meningitis after genital herpes / J. R.Berger // Lancet. — 1991. — Vol. 337(8753). — P. 1360-1361;36.Schlesinger Y. Herpes simplex virus type 2 meningitis in the absence of genitallesions: improved recognition with use of the polymerase chain reaction / Y.Schlesinger, P. Tebas, M. Gaudreault-Keener, R. S. Buller, G. A. Storch //Clinical Infectious Diseases.
— 1995. — Vol. 20(4). — P. 842–848;10237.Aurelius E. Neurologic morbidity after herpes simplex virus type 2 meningitis: aretrospective study of 40 patients / E. Aurelius, M. Forsgren, E. Gille, B.Skoldenberg // Scandinavian Journal of Infectious Diseases. — 2002. — Vol.34(4). — P. 278–283;38.Tang Y. W. Analysis of candidate-host immunogenetic determinants in herpessimplex virus-associated Mollaret's meningitis / Y. W. Tang, P. J.
Cleavinger, H.J. Li, P. S. Mitchell, T. F. Smith, D. H. Persing // Clinical Infectious Diseases. —2000. — Vol. 30(1). — P. 176–178;39.Monteyne P. Recurrent meningitis and encephalitis associated with herpessimplex type 2: demonstration by polymerase chain reaction / Р. Monteyne, C. J.Sindic, E. C. Laterre // European Neurology. — 1996. — Vol. 36(3). — P. 176177;40.Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella-zostervirus infections / A. Sauerbrei // European Journal of Clinical Microbiology &Infectious Diseases. — 2016.
— Vol. 35(5). — P. 723–734;41.Bourne N. Efficacy and toxicity of zinc salts as candidate topicalmicrobicidesagainst vaginal herpes simplex virus type 2 infection / N. Bourne, R.Stegall, R. Montano, M. Meador, L. R. Stanberry, G. N. Milligan // AntimicrobialAgents and Chemotherapy. — 2005. — Vol. 49(3). — P. 1181–1183;42.Harpaz R. Advisory Committee on Immunization Practices (ACIP) Centers forDisease Control and Prevention (CDC). Prevention of herpes zoster:recommendations of the Advisory Committee on Immunization Practices (ACIP)/ R.
Harpaz, I. R. Ortega-Sanchez, J. F. Seward // Morbidity and MortalityWeekly Report. — 2008. — Vol. 57(RR-5). — P. 1–30;43.Rock D. L. Latent herpes simplex virus type 1 DNA contains two copies of thevirion DNA joint region / D. L. Rock, N. W. Fraser // Journal of Virology. —1985. — Vol. 55(3). — P. 849–852;44.del Rio T. Actin is a component of the compensation mechanism in pseudorabiesvirus virions lacking the major tegument protein VP22 / Т. del Rio, C. J. Decoste,L.W.
Enquist // Journal of Virology. — 2005. — Vol. 79(13). — P. 8614–8619;10345.Meijering E. Methods for cell and particle tracking / E. Meijering, O.Dzyubachyk, I. Smal // Methods in Enzymology. — 2012. — Vol. 504. — P.183–200;46.Eda I. Acute hemiplegia with lacunar infarct after varicella infection in childhood/ I. Eda, S. Takashima, K. Takeshita // Brain and Development. — 1983. — Vol.5. — P. 494–499;47.Gilden D. Varicella zoster virus vasculopathies: diverse clinical manifestations,laboratory features, pathogenesis, and treatment / D. Gilden, R. J. Cohrs, R.Mahalingam, M.
A. Nagel // Lancet Neurology. — 2009. — № 8. — P. 731– 740;48.Askalan R. Chickenpox and stroke in childhood: a study of frequency andcausation / R. Askalan, S. Laughlin, S. Mayank, А. Chan, D. MacGregor, M.Andrew, R. Curtis, B. Meaney, G. deVeber // Stroke. — 2001. — Vol. 32. — P.1257–1262;49.Nagel M. A. The varicella zoster virus vasculopathies: clinical, CSF, imaging,and virologic features / М.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
